Scribd Logo
Upload

Welcome to Scribd!

  • Covid 19 Analysis

    Uploaded by

    Jana Taboada
    5 views1 page
    The document analyzes the COVID-19 vaccine development landscape as of May 2020. It discusses that there were over 100 vaccine candidates in preclinical testing, with 11 in clinical evaluation including mRNA-1273 from Moderna, Ad5-nCoV from CanSino, and BNT162 from Pfizer/BioNTech. Several of the candidates aimed to elicit neutralizing antibodies against the SARS-CoV-2 spike protein.

    Original Description:

    Original Title

    Covid 19 analysis

    Copyright

    © © All Rights Reserved

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    The document analyzes the COVID-19 vaccine development landscape as of May 2020. It discusses that there were over 100 vaccine candidates in preclinical testing, with 11 in clinical evaluation including mRNA-1273 from Moderna, Ad5-nCoV from CanSino, and BNT162 from Pfizer/BioNTech. Several of the candidates aimed to elicit neutralizing antibodies against the SARS-CoV-2 spike protein.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    5 views1 page

    Covid 19 Analysis

    Uploaded by

    Jana Taboada
    The document analyzes the COVID-19 vaccine development landscape as of May 2020. It discusses that there were over 100 vaccine candidates in preclinical testing, with 11 in clinical evaluation including mRNA-1273 from Moderna, Ad5-nCoV from CanSino, and BNT162 from Pfizer/BioNTech. Several of the candidates aimed to elicit neutralizing antibodies against the SARS-CoV-2 spike protein.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 1

    Covid 19 analysis

    Le, T.T., Andreadakis, Z., Kumar, A., Román, R.G., Tollefsen, S., Saville, M. and Mayhew, S., 2020. The
    COVID-19 vaccine development landscape. Nat Rev Drug Discov, 19(5), pp.305-306.

    You might also like